|Home | About | Journals | Submit | Contact Us | Français|
Currently, gastric cancer (GC) is considered a public health problem worldwide. Using medicinal plants for the prevention of chronic diseases such as cancer constitutes new alternatives in traditional medicine. Oenothera rosea (OR) could be an option, but it needs to be evaluated.
The main objective of this study was to evaluate the protective effect of OR extract on N-methyl-N-nitrosourea (NMU)-induced GC in rats.
In total, 80 male Holtzman rats were randomized into five groups. Group A received the saline solution (5mL/kg), group B received NMU 500 μg/kg (cancer inductor) by oral administration for 16 weeks, and groups C, D, and E were treated with OR extract (100, 200, and 300 mg/kg, respectively) and NMU in order to evaluate the preventive effect on cancer induced by NMU for 16 weeks. Blood and histological samples of stomachs were collected to determine histopathological, biochemical, and hematological parameters between different experimental groups.
Groups C, D, and E presented less histopathological changes such as anaplastic and hyperplastic cells, compared with group B. Hematological and biochemical parameters were recorded, and superoxide dismutase, malondialdehyde, and nitric oxide levels were statistically less than those of NMU group (P<0.05, P<0.01, and P<0.01).
Considering the histopathological signs and the antioxidant activity in vivo as well as hematological and biochemical parameters of ethanolic extract of OR, we concluded that its administration in rats has a protective effect on GC, which is induced experimentally. This species could be studied in clinical trials for patients with GC in the future.
Gastric cancer (GC) is the third leading cause of death worldwide. For example, Eastern Asian and Latin-American countries have a higher incidence of GC.1 On the other hand, the annual incidence of GC in Peruvian population is ranked in the 20th position in the world, ~15.8 per 100,000 habitants, five times higher than that in the USA.2,3
Surgical resection and chemotherapy are the only potentially curative treatments for GC. Currently, the major percentage of diagnosed cancer is determined in the final or advanced stage, representing 75% of all diagnosed cases. Furthermore, <5% of patients with advanced GC survive up to 5 years.4
Bioassays in animals play an important role in understanding GC pathophysiology. A high intake of salt, nitrates/nitrites, and nitrosamines is known as the main factor inducing GC.5 These synthetic N-nitroso compounds, such as N-methyl-N-nitrosourea (NMU), have been used in experimental gastric carcinogenesis, inducing DNA mutations, and could modify the amino acids in histone proteins, leading to a chromatin remodeling.6
Many medicinal plants are used by the patients with cancer due to numerous positive effects of these plants on pain relief, vomiting, nauseas, depression, and anxiety.7 The World Health Organization released a statement about the increased risk of GC with a large intake of salt-preserved foods. However, diets high in raw vegetables, fresh fruits, vitamin C, vitamin A, and antioxidants are associated with a decreased risk of GC.8 Polyphenols have antioxidant capacity with potential benefits for health and could reduce cancer risk, by blocking the initial stage of carcinogenesis, free radicals, activating glutathione peroxidase, and glutathione reductase and stopping the activation of glutathione S transferase.9
Oenothera rosea (OR; family: Onagraceae) is called “chupasangre,” and it is a species with therapeutic properties from Peruvian flora, especially from the high mountain. The infusion of this plant is used for its antibacterial and anticoagulant effects. Previous research has reported that OR presents flavonoids and steroids.10 The main objective of the present research was to determine the protective effect of OR on NMU-induced GC in Holtzman rats.
A total of 80 male Holtzman rats (80±20 g) were obtained from the National Institute of Health (Lima, Peru). The rats were kept in plastic cages with access to pelletized food and water ad libitum and housed in an animal room at a controlled temperature (22–24°C) and 12-h light/dark cycle. The rats were randomized into five groups of 16 animals each and acclimatized 15 days prior to the experiments. All the experimental procedures involving animals were conducted in accordance with the guidelines established by the European Union on Animal Care (European Economic Community Council 86/609) and approved by the Institute for Ethics in Health of the Universidad Nacional Mayor de San Marcos (01414-R-12-UNMSM).
NMU, sodium nitroprusside, sulfanilic acid reagent, thiobarbituric acid, and trichloro acetic acid were purchased from Sigma-Aldrich (St Louis, MO, USA).
OR was collected, in February 2016, from Valle del Mantaro, Huancayo, Peru. A voucher specimen (152-USM-2016) was deposited at the National Herbarium of UNMSM, Lima, Peru.
The whole plant of OR (1000 g) was dried at room temperature and pulverized at the Pharmacology Laboratory, Faculty of Medicine, UNMSM; the powder material was exhaustively soaked with 96% ethanol and intermittently shaken every day for 7 days. The extract was filtered and evaporated by using a rotavap. The crude ethanolic extract obtained (50 g) was stored until further studies.
The presence of phytochemical constituents, such as alkaloids, terpenoids, quinone, flavonoids, tannins, saponins, steroids, and phenolic compounds, was determined using the standard qualitative phytochemical methods described.11
In all groups, except negative control, tumor induction was carried out following the method of Tatematsu et al12 with brief modifications. NMU was used as a carcinogenic agent for GC induction. Animals received a single dose of 500 μg/kg of NMU dissolved in saline solution (pH 5.0) by oral administration for 16 weeks.
The groups were placed according to the treatment and dose in mg/kg. OR refers to OR ethanolic extract. The negative control group received saline solution (10 mL/kg) orally. NMU group was induced with NMU 500 μg/kg orally for 16 weeks. NMU + OR-100, NMU + OR-200, and NMU + OR-300 groups received OR (100, 200, and 300 mg/kg, respectively) orally for 16 weeks with NMU inductor. Both solutions were administered by separate intervals to avoid interactions.
At the end of the experiment, the rats were weighed. Blood samples were collected to assess the biochemical parameters and hematological indicators. The animals were sacrificed by using pentobarbital anesthesia (100 mg/kg; intraperitoneally). The protective effect was determined evaluating weights, histopathological signs, and hematological and biochemical indicators, as well as superoxide dismutase (SOD),13 nitric oxide (NO),14 and malondialdehyde (MDA).15
Stomachs were removed and fixed in 10% formalin, processed, and embedded into paraffin blocks. Sections were cut at 5 μm thickness and stained with hematoxylin and eosin. The slides were examined under a light microscope (Olympus BX51; Olympus Corporation, Tokyo, Japan).
Data are presented as mean ± standard deviation and were analyzed for homogeneity of variance by the Levene test and normality by the Wilk–Shapiro W-statistics. One-way analysis of variance followed by Duncan multiple comparison method was carried out to compare the mean values of different groups. A P-value of 0.05 was considered statistically significant in all cases. Data were analyzed by using SPSS Version 21 (IBM Corporation, Armonk, NY, USA).
During the experimental process, international ethical principles for research using laboratory animals were respected. The rats were euthanized by intravenous injection of pentobarbital (100 mg/kg). This method leads to a quick and peaceful death, acceptable for rats.
The qualitative analysis revealed the presence of secondary metabolites in the ethanolic extract of OR such as terpenes, flavonoids, tannins, phenolic compounds, alkaloids, and saponins (Table 1).
As shown in Table 2, hematological indicators show that triglycerides, cholesterol, leukocytes, high-density lipoprotein (HDL), glucose, urea, alanine aminotransferase (ALT), and alkaline phosphatase (PA) levels were significantly less in OR200 + NMU and OR300 + NMU groups (P<0.01 and P<0.01, respectively) than in NMU group. NMU administration at doses of 500 μg/kg significantly increased the levels of ALT and PA (P<0.01 and P<0.01, respectively) compared with normal group.
Biochemical indicators showed that the SOD, NO, and MDA levels were significantly less in NMU+ OR100 and NMU + OR300 groups (P<0.05 and P<0.01) than in NMU group. Administration of OR at the dose of 200 mg/kg significantly reduced the SOD level (P<0.05) as compared with NMU group (Table 3).
The results showed that groups treated with 100, 200, and 300 mg/kg body weight extract had an increased body weight. A significant increase in body weight was found in OR300 + NMU group (230.21±18 g; P<0.01; compared with NMU group). OR100 + NMU and OR200 + NMU groups also were effective during the experiment and presented significant values (168.55±21 g, P<0.05; 185.45±12 g; P<0.01, respectively) compared with NMU group (Figure 1).
Figure 2 shows the results of OR extract treatments on stomach histology. These results are in accordance with the results from hematological and biochemical level studies. It was found that the stomachs among the normal control rats had a normal histological appearance. However, stomachs in NMU group are abnormal with anaplastic and dysplastic cells. The rats treated with OR (OR200 + NMU and OR300+ NMU) had the improved histological appearances of stomachs.
Phytochemical analysis revealed the presence of different secondary metabolites (Table 1), and these compounds have not been identified until now. Phytocompounds are organic compounds that possess many medicinal properties; for instance, flavonoids have been associated with a reduced risk of GC, except for anthocyanidins and isoflavones.16
Otherwise, NMU is a tumor agent that has a high affinity by H2 instead of H1 receptors; furthermore, these receptors have different systems of second messengers, producing cell proliferation such as differenced and transformed cells.17 NMU has mutagen and genotoxic properties, with a potent inductor of cellular stress, leading to chromosomal aberrations, point mutations, cell death, and DNA damage.18
GC induced by NMU in rats is located mainly in the gastric antrum with uniformly well-differentiated or moderately differentiated adenocarcinomas.19 In mice treated with NMU (500 μg, weekly, intragastric intubation), after the removal of the forestomach, it has been evidenced well-differentiated adenocarcinoma in their glandular stomach with 100% incidence within 40 weeks.20 In our experiment, the tumor induction was reproduced for 16 weeks.
Dysplasia is more biologically related to malignant transformation of gastric mucosa, and in this study, all animals that received the tumor-inducing agent showed a great quantity of anaplastic cells, especially in groups treated with OR. The age of animals possibly influenced that dysplasia was not the predominant pattern.21 In our study, the rats were 4 months old (young adults), which allowed their tissues respond less aggressively. The histological pattern found in the rats given ethanol extract of OR showed discrete hyperplastic and anaplastic figures with fibrotic areas. Furthermore, the efficiency of tumor induction by NMU in other studies depended on its concentration rather than total intake.22
Hematological parameters showed a significant increase in HDL level and a significant reduction in total cholesterol level in groups treated with OR. The lipid-lowering effect could directly influence the development of cancer.23 It has been evidenced in preclinical studies that statins show promising results in pancreatic cancer, liver cancer, colorectal cancer, and GC.24
MDA is a metabolite of the breakdown of unsaturated fatty acids into their essential chains through oxidative process.25 The relationship between GC and MDA levels remains controversial. In our study, the groups that received the extract showed significantly lower values of MDA. However, Murugan et al26 reported a significant reduction in MDA levels on N-methyl-N-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.
The effect of ethanol extract of OR on MDA, SOD, and NO levels could be due to the presence of flavonoids, which have the property of reducing the inflammatory mediators and significantly reduce the odds to develop a cancerous disease.27 The levels of MDA and SOD were significantly less in treated groups compared with NMU group. MDA is related to oxidative stress and oxidative degeneration, which is closely linked to the genesis of neoplasms and dysplasias.28
The limitations of this study include the lack of isolated metabolites present in the OR extract. In addition, its exact mechanism is unclear. This study includes an animal model that can be extrapolated to human beings in the future.
The data indicate the preventive potential in GC with a high therapeutic index. However, the complete mechanisms of those effects are unknown. Further studies are needed to identify more precisely the active molecules involved in the protective effect described.
In summary, the results obtained in this study confirmed that oxidative stress and histopathological, biochemical, and hematological changes are involved in GC; it can be inferred that bioactive metabolites of OR attenuated NMU-induced oxidative stress due to antioxidant activity on markers such as SOD, MDA, and NO. Considering the antitumorigenic, hypolipidemic, and antioxidant properties of OR, we concluded that it has a protective effect on NMU-induced GC in rats. There is a great potential to develop OR as a natural chemotherapeutic supplement in GC treatment.
The authors report no conflicts of interest in this work.